Phase II trial of recombinant interferon alfa‐2 in the treatment of primary systemic amyloidosis

Morie A. Gertz, Robert A. Kyle

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of recombinant interferon alfa‐2 in the treatment of primary systemic amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences